Holen Sie sich die Stockscreener-App
5.19
7.34%
0.355
Handel nachbörslich:
5.13
-0.06
-1.16%
Schlusskurs vom Vortag:
$4.835
Offen:
$4.81
24-Stunden-Volumen:
27,849
Relative Volume:
0.11
Marktkapitalisierung:
$13.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-58.52M
KGV:
-2.4833
EPS:
-2.09
Netto-Cashflow:
$-45.03M
1W Leistung:
+0.58%
1M Leistung:
+1,214%
6M Leistung:
+616.26%
1J Leistung:
+224.38%
1-Tages-Spanne:
$4.81
$5.23
1-Wochen-Bereich:
$4.75
$5.42
52-Wochen-Spanne:
$0.224
$6.42
Nextcure Inc Stock (NXTC) Company Profile
Firmenname
Nextcure Inc
Sektor
Branche
Telefon
240-399-4900
Adresse
9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD
Vergleichen Sie NXTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NXTC
Nextcure Inc
|
5.19 | 12.85M | 0 | -58.52M | -45.03M | -2.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Nextcure Inc Stock (NXTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-11-04 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2022-03-01 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2021-03-05 | Hochstufung | Truist | Hold → Buy |
| 2021-01-15 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2020-07-16 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-07-13 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2020-07-13 | Herabstufung | SunTrust | Buy → Hold |
| 2020-06-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-06-01 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-05-26 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-03-24 | Eingeleitet | The Benchmark Company | Buy |
| 2020-03-02 | Eingeleitet | ROTH Capital | Buy |
| 2020-01-13 | Eingeleitet | SunTrust | Buy |
| 2019-12-05 | Eingeleitet | Needham | Buy |
| 2019-11-26 | Eingeleitet | BTIG Research | Buy |
| 2019-07-09 | Eingeleitet | BofA/Merrill | Buy |
| 2019-06-03 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-06-03 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Nextcure Inc Aktie (NXTC) Neueste Nachrichten
Visualizing NextCure Inc. stock with heatmapsJuly 2025 Short Interest & Accurate Buy Signal Alerts - Newser
NextCure Inc. stock prediction for this weekWeekly Investment Recap & Weekly Breakout Stock Alerts - Newser
Using fundamentals and technicals on NextCure Inc.Market Performance Summary & Consistent Profit Focused Trading Strategies - Newser
Technical signs of recovery in NextCure Inc. [Rate Hike]Free Safe Investment Capital Preservation Plans - Newser
Technical signs of recovery in NextCure Inc.Technical Setup and Return Forecast Engine - Newser
NextCure Inc. stock volume spike explained2025 Growth vs Value & Risk Managed Investment Entry Signals - Newser
Will NextCure Inc. stock recover after recent dropTechnical Confirmation System with Signal Alerts - Newser
What makes NextCure Inc. stock price move sharplyFree High Accuracy Alerts for ROI Traders - Newser
Does NextCure Inc. qualify in momentum factor screeningFree Consistent Income Focused Trade List - Newser
Why NextCure Inc. stock attracts strong analyst attentionFree Accurate Technical Trend Reversal Picks - Newser
Backtesting results for NextCure Inc. trading strategiesFree Short Term Trading Opportunity Watch - Newser
Published on: 2025-08-11 00:58:31 - Newser
How to monitor NextCure Inc. with trend dashboardsStock Forecast Tools for Retail Traders - Newser
How NextCure Inc. stock performs during market volatilityCapital Secure Pattern Signal Analysis Sheet - Newser
NextCure Inc. Company Revenue and Profit Trends: A Deep DiveMomentum Stocks with Breakout Potential - Newser
Is it time to cut losses on NextCure Inc.Early Entry Ideas with Momentum Potential - Newser
NextCure Inc. Earnings Report Breakdown: What Investors Should KnowConservative Investment Setup and Risk Analysis - Newser
NextCure Reports Q2 2025 Earnings, Partners with Simcere Zaiming, and Advances Clinical Trials - AInvest
NextCure (NXTC) Q2 Loss Widens 71% - AOL.com
NextCure Reports Q2 2025 Results and Strategic Updates - TipRanks
NextCure Inc reports results for the quarter ended June 30Earnings Summary - TradingView
NextCure (NXTC) Q2 Loss Widens 71% - The Motley Fool
NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results - The Manila Times
NextCure's Dual ADC Cancer Programs Progress: Strategic Partnership Fuels Clinical Advancement - Stock Titan
Short interest data insights for NextCure Inc.Long-Term Investment Strategy Impact Analysis - Newser
Fibonacci Support Holding Strong in NextCure Inc.Swing Trade Plans Emphasize Risk Management - beatles.ru
What indicators show strength in NextCure Inc.Free Low Risk Picks for Daily Trading - Newser
What are the latest earnings results for NextCure Inc.Superior risk-adjusted returns - Jammu Links News
When is NextCure Inc. stock expected to show significant growthRapidly expanding wealth - Jammu Links News
What drives NextCure Inc. stock priceBreakthrough stock performance - Jammu Links News
Published on: 2025-08-03 14:04:52 - Jammu Links News
Is it the right time to buy NextCure Inc. stockBuild a diversified portfolio for risk mitigation - Jammu Links News
How does NextCure Inc. generate profit in a changing economyTremendous return rates - Jammu Links News
Is NextCure Inc. a good long term investmentSuperior stock growth - Jammu Links News
Finanzdaten der Nextcure Inc-Aktie (NXTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):